Related Experiment Videos
Overall risk of left ventricular hypertrophy secondary to systemic hypertension
1Morehouse School of Medicine, Atlanta, Georgia.
Insights
Electrocardiograms are limited for assessing left ventricular hypertrophy in mild hypertension. Echocardiography offers higher sensitivity and specificity, indicating its potential importance for cardiovascular risk stratification.
Area of Science:
- Cardiology
- Medical Imaging
- Hypertension Research
Background:
- Cardiovascular event risk stratification is crucial for hypertensive patients.
- Left ventricular (LV) hypertrophy assessment is a key component of risk stratification.
- Electrocardiogram (ECG) has low prevalence (<3%) of LV hypertrophy detection in mild hypertension, limiting its utility.
Purpose of the Study:
- To evaluate the utility of echocardiography for detecting and assessing left ventricular hypertrophy in hypertensive patients.
- To critically assess the risk associated with echocardiographically detected LV hypertrophy.
- To determine the clinical and public health importance of echocardiography in hypertension management.
Main Methods:
- Utilized echocardiography to detect and assess LV hypertrophy, its severity, and forms.
- Compared echocardiography's sensitivity and specificity to electrocardiography for LV hypertrophy detection.
- Reviewed initial information on risks associated with echocardiographically detected LV mass increases.
Main Results:
- Echocardiography demonstrates significantly higher sensitivity (approx. 10-fold) and specificity for LV hypertrophy detection compared to ECG.
- Initial data suggest considerable cardiovascular risk associated with echocardiographically detected LV hypertrophy.
- Echocardiography appears to be a valuable tool for assessing LV hypertrophy in hypertensive individuals.
Conclusions:
- Echocardiography is a more sensitive and specific tool than ECG for detecting LV hypertrophy in hypertensive patients, especially those with mild or borderline hypertension.
- Echocardiographically detected LV hypertrophy carries considerable cardiovascular risk, highlighting its clinical significance.
- Further cost-benefit analyses are required to define echocardiography's precise role in evaluating patients with borderline and mild hypertension.
Abstract:
Stratification of risk for cardiovascular events is a fundamental aspect of the assessment of hypertensive patients. The assessment of left ventricular (LV) hypertrophy is an important component of such stratification. The low prevalence of LV hypertrophy on the electrocardiogram (less than 3%) in patients with borderline or mild hypertension limits the utility of the electrocardiogram for stratification of risk in such patients. The high sensitivity (roughly 10-fold greater) and specificity of echocardiography for detection of LV hypertrophy and assessment of the severity and the various forms of such hypertrophy have prompted critical evaluation of the risk associated with such LV hypertrophy. Initial information suggesting considerable risk associated with echocardiographically detected increases in LV mass suggests significant clinical and public health importance of this tool. Further detailed cost-benefit analyses are needed to aid in assessing the role of echocardiography in the evaluation of patients with borderline and mild hypertension.